P
Peter D. Schellinger
Researcher at Ruhr University Bochum
Publications - 262
Citations - 18189
Peter D. Schellinger is an academic researcher from Ruhr University Bochum. The author has contributed to research in topics: Stroke & Thrombolysis. The author has an hindex of 64, co-authored 240 publications receiving 15911 citations. Previous affiliations of Peter D. Schellinger include University Hospitals of the Ruhr-University of Bochum & Heidelberg University.
Papers
More filters
Journal ArticleDOI
Characteristics in Non-Vitamin K Antagonist Oral Anticoagulant-Related Intracerebral Hemorrhage.
Stefan T. Gerner,Joji B. Kuramatsu,Jochen A. Sembill,Maximilian I. Sprügel,Manuel Hagen,Ruben U. Knappe,Matthias Endres,Karl Georg Haeusler,Karl Georg Haeusler,Jan Sobesky,Johannes Schurig,Sarah Zweynert,Miriam Bauer,Peter Vajkoczy,Peter A. Ringleb,Jan C. Purrucker,Timolaos Rizos,Jens Volkmann,Wolfgang Müllges,Peter Kraft,Anna-Lena Schubert,Frank Erbguth,Martin Nueckel,Peter D. Schellinger,Jörg Glahn,Ulrich J. Knappe,Gereon R. Fink,Christian Dohmen,Henning Stetefeld,Anna Lena Fisse,Jens Minnerup,Georg Hagemann,Florian Rakers,Heinz Reichmann,Hauke Schneider,Jan Rahmig,Albert C. Ludolph,Sebastian Stösser,Hermann Neugebauer,Joachim Röther,Peter Michels,Michael P. Schwarz,Gernot Reimann,Hansjörg Bäzner,Henning Schwert,J Claßen,Dominik Michalski,Armin J. Grau,Frederick Palm,Christian Urbanek,Johannes C. Wöhrle,Fahid Alshammari,Markus Horn,Dirk Bahner,Otto W. Witte,Albrecht Günther,Gerhard F. Hamann,Tobias Engelhorn,Hannes Lücking,Arnd Dörfler,Stefan Schwab,Hagen B. Huttner +61 more
TL;DR: If effectively anticoagulated, there were no differences in hematoma characteristics and functional outcome among patients with NOAC- or VKA-related ICH, and type of NOAC agent or differentNOAC-dosing regimens did not result in relevant differences in imaging characteristics or outcome.
Journal ArticleDOI
Percutaneous Left Atrial Appendage Occlusion for the Prevention of Stroke in Patients with Atrial Fibrillation: Review and Critical Appraisal.
TL;DR: The authors review the current status of percutaneous left atrial appendage occlusion therapy in patients with atrial fibrillation with the goal to prevent ischemic stroke and systemic embolism and to reduce oral anticoagulation associated bleeding.
Journal ArticleDOI
Safety and Feasibility of NeuroFlo Use in Eight- to 24–Hour Ischemic Stroke Patients:
Maxim D. Hammer,Lee H. Schwamm,Sidney Starkman,Peter D. Schellinger,Tudor G Jovin,Raul G. Nogueira,W. S. Burgin,Souvik Sen,Hans-Christoph Diener,Timothy Watson,Patrik Michel,Ashfaq Shuaib,William P. Dillon,David S Liebeskind +13 more
TL;DR: Partial aortic occlusion using the NeuroFlo catheter, a novel collateral therapeutic strategy, appears safe and feasible in stroke patients eight-hours to 24 h after symptom onset.
Journal ArticleDOI
Nasal meningoencephalocele, an unusual cause for recurrent meningitis. Case report and review of the literature.
Martin Köhrmann,Martin Köhrmann,Peter D. Schellinger,Peter D. Schellinger,Axel Wetter,Stefan Hähnel +5 more
TL;DR: The case of a 56 year old male with bacterial meningitis who was admitted to the NICU and diagnosed with a posttraumatic meningoencephalocele, which allows detection of the composition of the cyst and thereby facilitates planning of the operative treatment.
Journal ArticleDOI
Favorable Vascular Profile is an Independent Predictor of Outcome A Post Hoc Analysis of the Safety and Efficacy of NeuroFlo Technology in Ischemic Stroke Trial
Peter D. Schellinger,Martin Köhrmann,Songling Liu,William P. Dillon,Raul G. Nogueira,Ashfaq Shuaib,David S Liebeskind +6 more
TL;DR: FVP is a novel parameter to predict outcome of acute stroke patients and further studies will establish its potential role for selection of optimal candidates for hemodynamic augmentation.